EcoDrugPlus

Phosphodiesterase 5a, Cgmp-Specific

Ensembl ID : ENSMSIG00000015248
Gene Symbol: PDE5A
1 Cross references
235 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSMSIG00000002359
Gene Symbol: PDE7A
1 Cross references
268 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSMSIG00000029540
Gene Symbol: PDE7B
1 Cross references
204 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSMSIG00000011826
Gene Symbol: PDE9A
1 Cross references
295 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSMSIG00000003525
Gene Symbol: PIK3R1
1 Cross references
218 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 2

Ensembl ID : ENSMSIG00000032078
Gene Symbol: PIK3R2
1 Cross references
268 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 3

Ensembl ID : ENSMSIG00000014768
Gene Symbol: PIK3R3
1 Cross references
289 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSMSIG00000008355
Gene Symbol: PIK3R5
1 Cross references
270 Possible Orthologues:

Phospholipase A2, Group Vii (Platelet-Activating Factor Acetylhydrolase, Plasma)

Ensembl ID : ENSMSIG00000024173
Gene Symbol: PLA2G7
1 Cross references
218 Possible Orthologues:

Phosphoribosylglycinamide Formyltransferase

Ensembl ID : ENSMSIG00000006503
Gene Symbol: GART
1 Cross references
230 Possible Orthologues:

Plasminogen

Ensembl ID : ENSMSIG00000024831
Gene Symbol: PLG
1 Cross references
254 Possible Orthologues:

Plasminogen Activator, Tissue

Ensembl ID : ENSMSIG00000022138
Gene Symbol: PLAT
1 Cross references
219 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).